These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 6392232)

  • 1. Relevance of peak and trough concentrations to antimicrobial drug therapy.
    Koritz GD
    J Am Vet Med Assoc; 1984 Nov; 185(10):1072-5. PubMed ID: 6392232
    [No Abstract]   [Full Text] [Related]  

  • 2. A rational approach to the selection of an antimicrobial agent.
    Hirsh DC; Ruehl WW
    J Am Vet Med Assoc; 1984 Nov; 185(10):1058-61. PubMed ID: 6392230
    [No Abstract]   [Full Text] [Related]  

  • 3. Selecting therapeutic concentrations: minimum inhibitory concentrations vs subminimum or supraminimum inhibitory concentrations.
    Powers TE; Varma KJ; Powers JD
    J Am Vet Med Assoc; 1984 Nov; 185(10):1062-7. PubMed ID: 6392231
    [No Abstract]   [Full Text] [Related]  

  • 4. Therapeutic strategies involving antimicrobial treatment of disseminated bacterial infection in small animals.
    Garvey MS; Aucoin DP
    J Am Vet Med Assoc; 1984 Nov; 185(10):1185-9. PubMed ID: 6392253
    [No Abstract]   [Full Text] [Related]  

  • 5. Therapeutic decisions. Choosing appropriate antimicrobial therapy.
    Wilcke JR
    Probl Vet Med; 1990 Jun; 2(2):279-89. PubMed ID: 2134592
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Therapeutic strategies involving antimicrobial treatment of the gastrointestinal tract in small animals.
    Dillon R
    J Am Vet Med Assoc; 1984 Nov; 185(10):1169-71. PubMed ID: 6392249
    [No Abstract]   [Full Text] [Related]  

  • 7. The challenge of antibiotic resistant bacterial pathogens: the medical need, the market and prospects for new antimicrobial agents.
    Payne D; Tomasz A
    Curr Opin Microbiol; 2004 Oct; 7(5):435-8. PubMed ID: 15451496
    [No Abstract]   [Full Text] [Related]  

  • 8. [Antimicrobial susceptibility testing of bacteria isolated from animals: considerations concerning the predefinition of breakpoints from the clinical pharmacological viewpoint].
    Kietzmann M; Böttner A; Hafez HM; Kehrenberg C; Klarmann D; Krabisch P; Kühn T; Luhofer G; Richter A; Schwarz S; Traeder W; Waldmann KH; Wallmann J; Werckenthin C; ;
    Berl Munch Tierarztl Wochenschr; 2004; 117(3-4):81-7. PubMed ID: 15046455
    [TBL] [Abstract][Full Text] [Related]  

  • 9. What is inadequate antibacterial therapy?
    Moellering RC
    Clin Infect Dis; 2009 Oct; 49(7):1006-8. PubMed ID: 19719418
    [No Abstract]   [Full Text] [Related]  

  • 10. [Cephalexin: microbiological activity in vitro and in vivo].
    Muggleton PW; Renzini G; Ravagnan G; Orsolini P
    Antibiotica; 1969 Jun; 7(2):93-128. PubMed ID: 5399239
    [No Abstract]   [Full Text] [Related]  

  • 11. Antibiograms of pathogenic bacteria isolated from laboratory rabbits in Ibadan, Nigeria.
    Okewole EA; Olubunmi PA
    Lab Anim; 2008 Oct; 42(4):511-4. PubMed ID: 18840619
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Future developments in the aminoglycoside group of antimicrobial drugs.
    Benitz AM
    J Am Vet Med Assoc; 1984 Nov; 185(10):1118-23. PubMed ID: 6392239
    [No Abstract]   [Full Text] [Related]  

  • 13. Mechanisms of bacterial resistance to antimicrobial agents.
    Stratton CW
    J Med Liban; 2000; 48(4):186-98. PubMed ID: 11214188
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Selecting empiric antibiotic therapy in an era of multi-drug resistance--is the cupboard really bare? Introduction.
    Collatz E
    Clin Microbiol Infect; 2008 Dec; 14 Suppl 6():1. PubMed ID: 19040460
    [No Abstract]   [Full Text] [Related]  

  • 15. [Cross-resistance between antimicrobial agents used in veterinary medicine: molecular background and practical consequences for susceptibility testing].
    Werckenthin C; Böttner A; Hafez HM; Hartmann K; Kaske M; Kehrenberg C; Kietzmann M; Klarmann D; Klein G; Krabisch P; Kühn T; Luhofer G; Richter A; Schulz B; Schwarz S; Sigge C; Traeder W; Waldmann KH; Wallmann J;
    Berl Munch Tierarztl Wochenschr; 2005; 118(11-12):471-80. PubMed ID: 16318271
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Acute otitis media: antimicrobial therapy in an era of resistant bacteria and sceptical meta-analysticians.
    Teele DW
    N Z Med J; 2000 Jul; 113(1113):284-6. PubMed ID: 10935569
    [No Abstract]   [Full Text] [Related]  

  • 17. [Development of resistance in infectious agents of agricultural animals in Germany (1990-1994)--a review].
    Trolldenier H
    Dtsch Tierarztl Wochenschr; 1996 Jul; 103(7):256-60. PubMed ID: 8998938
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Whither antibacterial drug discovery?
    Projan SJ
    Drug Discov Today; 2008 Apr; 13(7-8):279-80. PubMed ID: 18405838
    [No Abstract]   [Full Text] [Related]  

  • 19. HMR-3562. Aventis Pharma.
    Ma Z; Florjancic AS
    Curr Opin Investig Drugs; 2001 Dec; 2(12):1702-5. PubMed ID: 11892931
    [TBL] [Abstract][Full Text] [Related]  

  • 20. How to fight antimicrobial resistance.
    Foucault C; Brouqui P
    FEMS Immunol Med Microbiol; 2007 Mar; 49(2):173-83. PubMed ID: 17181560
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.